- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-27-0002664

Ucaili Pharma Private Limited
About Ucaili Pharma Private Limited
Data last updated:
Ucaili Pharma Private Limited is a private limited company based in Purnia, Bihar, India. It operates in the wholesale trading and distribution segment of the business services sector. It was incorporated on 13 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51100BR2018PTC037452. Its GSTIN is 10AACCU2177M1ZC (Bihar).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Payal Jha and Mani Gaurav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O. – Mitu Jha W/O. – Pankaj Kumar Sarvodaya Nagar Zila School, Purnia, Bihar, India – 854301.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.07 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹16.66 Lakh (net margin 5.4%) and EBITDA of ₹22.64 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 42% over five years.
Ucaili Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-27-0002664).
Company details
Recognitions & Rankings of Ucaili Pharma
Contact details
Ucaili Pharma Private Limited's registered office is in Purnia, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O. – Mitu Jha W/O. – Pankaj Kumar Sarvodaya Nagar Zila School, Purnia, Bihar, India – 854301
- IndustryBusiness Services, Wholesale, Contractual Work
To see the full contact details of Ucaili Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ucaili Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ucaili Pharma Private Limited, buy the company report.
Financials of Ucaili Pharma Private Limited
FY 2025 filings availableUcaili Pharma Private Limited reported revenue of ₹3.07 Cr (up 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 31% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ucaili Pharma Private Limited, buy the company report.
Board of directors of Ucaili Pharma Private Limited
Ucaili Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Payal Jha Also directs: Mecong Pharma Private Limited | Director | 13 Mar 2018 | 8 Years 8 Months | Current |
| Mani Gaurav Also directs: Mecong Pharma Private Limited | Director | 13 Mar 2018 | 8 Years 8 Months | Current |
Peer comparison
Ucaili Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bonne Sante Therapeutics (India) Limited | ₹3.07 Cr (FY 2025) | 17.0% | Ambala, Haryana, India | |||
| VCSP Nova Energie Private Limited | ₹3.07 Cr (FY 2025) | 18.0% | New Delhi, Delhi, India | |||
| Sitnez Biocare Private Limited | ₹3.07 Cr (FY 2025) | -11.0% | Chandigarh, India | |||
| Dhamoves Ventures Private Limited | ₹3.07 Cr (FY 2025) | -36.0% | Thirissur, Kerala, India | |||
| Graces Innovations and Services Private Limited | ₹3.07 Cr (FY 2025) | 2913.0% | Rudauli, Uttar Pradesh, India | |||
| Ucaili Pharma Private Limitedthis company | ₹3.07 Cr (FY 2024) | ₹16.66 Lakh | 5.4% | 31.0% | Purnia, Bihar, India | |
| JVJ Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2025) | 4.0% | Indore, Madhya Pradesh, India | |||
| Aristonics Private Limited | ₹3.07 Cr (FY 2024) | Hyderabad, Telangana, India | ||||
| Ablaze Industries India Private Limited | ₹3.07 Cr (FY 2025) | -28.0% | Meerut Road, Uttar Pradesh, India | |||
| Rajendra Polymers Private Limited | ₹3.07 Cr (FY 2025) | 11.0% | Auraiya, Uttar Pradesh, India | |||
| Motilal Makhanlal Foods Private Limited | ₹3.07 Cr (FY 2024) | 17.0% | Bargarh, Odisha, India |
To see the full peer comparison of Ucaili Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ucaili Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ucaili Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ucaili Pharma Private Limited has 1 active EPFO establishment as of Nov 21, 2026.
GST
Ucaili Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCU2177M1ZC | Bihar | Active | 11 May 2018 |
To see the full GST registrations and return filing status of Ucaili Pharma Private Limited, buy the company report.
Recent activity
Ucaili Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Mani Gaurav was appointed as Director on 13 Mar 2018.
Frequently asked questions
Ucaili Pharma is an active private limited company based in Purnia, Bihar, India. The company works in wholesale, within the business services industry. It was incorporated on 13 March 2018 (8+ years old) and is registered under CIN U51100BR2018PTC037452.
Ucaili Pharma has 2 current directors:
- Payal Jha - Director
- Mani Gaurav - Director
The latest financial statements of Ucaili Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ucaili Pharma is 10AACCU2177M1ZC, registered in Bihar.
The CIN (Corporate Identification Number) of Ucaili Pharma is U51100BR2018PTC037452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ucaili Pharma was incorporated on 13 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Ucaili Pharma by revenue are Bonne Sante Therapeutics (India) Limited, VCSP Nova Energie Private Limited, Sitnez Biocare Private Limited, Dhamoves Ventures Private Limited, Graces Innovations and Services Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mani Gaurav was appointed as Director on 13 Mar 2018. Payal Jha was appointed as Director on 13 Mar 2018.
Yes, Ucaili Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-27-0002664).
The registered office of Ucaili Pharma is at CO. – Mitu Jha WO. – Pankaj Kumar Sarvodaya Nagar Zila School, Purnia, Bihar, India – 854301.
Ucaili Pharma operates in the business services industry, in the wholesale segment.

